UB Paderborn / Katalog / Suche / in CDI

Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients

The American journal of psychiatry, 2018-05, Vol.175 (5), p.463-470

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?

Frontiers in psychiatry, 2020-03, Vol.11, p.94-94

2020

Link zum Volltext

Verfügbarkeit prüfen

CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry

Frontiers in pharmacology, 2021-04, Vol.12, p.650750-650750

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates

Clinical pharmacology and therapeutics, 2021-09, Vol.110 (3), p.750-758

2021

Link zum Volltext

Verfügbarkeit prüfen

Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials

European neuropsychopharmacology, 2024-04, Vol.81, p.43-52

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits

Clinical and translational science, 2023-01, Vol.16 (1), p.62-72

2023

Link zum Volltext

Verfügbarkeit prüfen

Molecular Mechanism and Clinical Relevance of Ketamine as Rapid-Acting Antidepressant

Drug development research, 2016-11, Vol.77 (7), p.414-422

2016

Link zum Volltext

Verfügbarkeit prüfen

Can Gi1 biased 5-HT2A inverse agonists improve the treatment of psychosis?

European neuropsychopharmacology, 2020-08, Vol.37, p.100-101

Jukic, MM

2020

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids

Cells (Basel, Switzerland), 2022-05, Vol.11 (10), p.1597

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis

JAMA psychiatry (Chicago, Ill.), 2021-03, Vol.78 (3), p.270

2021

Link zum Volltext

Verfügbarkeit prüfen

The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients

Clinical pharmacology and therapeutics, 2022-05, Vol.111 (5), p.1165-1174

2022

Link zum Volltext

Verfügbarkeit prüfen

Significantly lower CYP2D6 metabolism measured as the O/N‐desmethylvenlafaxine metabolic ratio in carriers of CYP2D641 versus CYP2D69 or CYP2D610: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients

British journal of clinical pharmacology, 2019-01, Vol.85 (1), p.194-201

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study

The Lancet. Psychiatry, 2019-05, Vol.6 (5), p.418-426

2019

Link zum Volltext

Verfügbarkeit prüfen

CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability

Psychiatry research, 2022-06, Vol.312, p.114535-114535, Article 114535

2022

Link zum Volltext

Verfügbarkeit prüfen

Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients

Psychiatry research, 2018-11, Vol.269, p.746-752

2018

Link zum Volltext

Verfügbarkeit prüfen

The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia

Neuropathology and applied neurobiology, 2023-02, Vol.49 (1), p.e12867-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population

Clinical and translational science, 2022-09, Vol.15 (9), p.2135-2145

2022

Link zum Volltext

Verfügbarkeit prüfen

Otx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic Neurons

PloS one, 2015-10, Vol.10 (10), p.e0139697-e0139697

2015

Link zum Volltext

Verfügbarkeit prüfen

Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool

Frontiers in molecular neuroscience, 2017-11, Vol.10, p.372-372

2017

Link zum Volltext

Verfügbarkeit prüfen

BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons In Vivo and in Human Induced Pluripotent and Neural Stem Cells

The Journal of neuroscience, 2018-02, Vol.38 (7), p.1662-1676

2018

Link zum Volltext

Verfügbarkeit prüfen

A Novel CYP2C‐Haplotype Associated With Ultrarapid Metabolism of Escitalopram

Clinical pharmacology and therapeutics, 2021-09, Vol.110 (3), p.786-793

2021

Link zum Volltext

Verfügbarkeit prüfen

Can G i1 biased 5-HT 2A inverse agonists improve the treatment of psychosis?

European neuropsychopharmacology, 2020-08, Vol.37, p.100

Jukić, Marin M

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients

Neuropsychopharmacology (New York, N.Y.), 2020-02, Vol.45 (3), p.570-576

2020

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool

Frontiers in molecular neuroscience, 2018-02, Vol.11, p.29-29

2018

Link zum Volltext

Verfügbarkeit prüfen

Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders

Schizophrenia research, 2021-02, Vol.228, p.590-596

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?

CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry

Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates

Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials

Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits

Molecular Mechanism and Clinical Relevance of Ketamine as Rapid-Acting Antidepressant

Can Gi1 biased 5-HT2A inverse agonists improve the treatment of psychosis?

Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids

Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis

The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients

Significantly lower CYP2D6 metabolism measured as the O/N‐desmethylvenlafaxine metabolic ratio in carriers of CYP2D641 versus CYP2D69 or CYP2D610: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients

Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study

CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability

Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients

The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia

Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population

Otx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic Neurons

Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool

BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons In Vivo and in Human Induced Pluripotent and Neural Stem Cells

A Novel CYP2C‐Haplotype Associated With Ultrarapid Metabolism of Escitalopram

Can G i1 biased 5-HT 2A inverse agonists improve the treatment of psychosis?

Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients

Corrigendum: Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool

Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders

Suchergebnisse filtern